Stories Related to Sanofi Launches Hostile $18.5 Billion Bid For Genzyme

Reuters: Top News, Reuters
Mon, 10/04/2010 - 8:20am

PARIS (Reuters) - French drugmaker Sanofi-Aventis launched a hostile bid for Genzyme at $69 per share on Monday, taking its $18.5 billion offer direct to shareholders after Genzyme management refused to negotiate.

Sections: news business

Topics: drugmaker genzyme hostile bid hostile takeover sanofi-aventis

Bayer to pay $1.1B for California firm Conceptus
Germany drug company Bayer AG says it intends to buy California-based Conceptus to expand its birth control offerings. Bayer said Monday it would launch a pupublicblic offer to pay $31.00 per share for all the stock in Conceptus, Inc. That means Bayer would pay $1.1 billion. More
As drug industry’s influence over research grows, so does the potential for bias
For drugmaker GlaxoSmithKline, the 17-page article in the New England Journal of Medicine represented a coup. The 2006 report described a trial that compared three diabetes drugs and concluded that Avandia, the company’s new drug, performed best. More
Netflix moves to block a hostile takeover
Netflix is moving to protect itself against hostile takeovers, less than a week after activist investor Carl Icahn disclosed a stake of nearly 10 percent in the online video company. Netflix Inc. said Monday that it has adopted a shareholder rights plan, also known as a poison pill. More
Drug Makers Stalled in a Cycle of Quality Lapses and Shortages
...These recent quality lapses at big drug companies show that contamination and shoddy practices extend well beyond the loosely regulated compounding pharmacies that have attracted attention because of their link to an outbreak of meningitis... [S]everal industry observers and former plant employees said that the recent quality issues were troubling and that manufacturers had been reluctant to fix problems because stopping production was simply too costly in a business where profits were driven by volume. More
Exclusive: GSK set for Human Genome takeover
GlaxoSmithKline is expected to announce a deal to buy Human Genome Sciences for about $2.8 billion as soon as Monday, ending a three-month hostile pursuit of the U.S. biotech company on friendly terms after sweetening its offer. More

Comment On This Story

More Movie News

More Business News

After my mom died, I thought I'd never enjoy the holidays again. It took me years to find joy in my grief.
Business Insider, Wednesday - 12/25/2024 - 11:50 AM
The author (not pictured) didn't feel like celebrating the holidays after the death of her mom. Kerkez/Getty ImagesMy mom made the holidays special. The first Christmas without her in 2018 I basically turned into The Grinch. I re-found joy in the holidays while also grieving my loss. My mother had a penchant for making things special.
More | Talk | Read It Later | Share
The 3-year bear market in home sales is finally over, research firm says. Here's how to invest for a rebound.
Business Insider, Wednesday - 12/25/2024 - 11:00 AM
AP Photo/Bill SikesUS home sales just ended a 39-month year-over-year decline, signaling the end of the bear market, NDR said. Affordability issues, driven by high mortgage rates, drove the 3-year decline in home sales activity. Investors could take advantage of the setup by buying the iShares U. S. Home Construction ETF, NDR said.
More | Talk | Read It Later | Share
The 4 most fascinating storylines in the creator economy that BI's reporters will be watching next year
Business Insider, Wednesday - 12/25/2024 - 10:04 AM
TikTok CEO Shou Chew pictured testifying before Congress. His app could soon be banned in the US. The Washington PostTikTok could be banned come January, but what are the other fascinating creator-economy stories? BI's media team rounded up the most intriguing stories for the year ahead. Our picks ranged from a battle between Spotify and YouTube to what will happen in "IRL social."There are many fascinating stories popping up in the creator economy every day.
More | Talk | Read It Later | Share
Judge lets lawsuit against former Granby Ranch ski CEO move ahead
Denver Post, Wednesday - 12/25/2024 - 08:00 AM
Though vocally skeptical of the allegations, a Denver judge has agreed to allow an aunt of former Granby Ranch ski area CEO Melissa Cipriani to investigate whether she used the ski area to fraudulently transfer money and evade the aunt’s $19 million court judgment. “I’m frustrated with this case,” Judge David Goldberg said at a Dec.
More | Talk | Read It Later | Share
The most anticipated upcoming Nintendo Switch games in 2025
ReadWriteWeb, Wednesday - 12/25/2024 - 07:00 AM
There’s no shortage of upcoming Nintendo Switch games coming in 2025, with next year seeing some of the Japanese company’s heavy hitters coming out. Additionally, we should hear word about the hotly anticipated Nintendo Switch 2 in the early months of next year as well. We’re expecting big things, as the swan song for Nintendo Switch games could be on the horizon.
More | Talk | Read It Later | Share
The best Nintendo Switch games for kids in 2024
ReadWriteWeb, Wednesday - 12/25/2024 - 05:00 AM
The best Nintendo Switch games for kids aren’t created equally. The perenially popular home console and handheld hybrid system is home to hundreds of titles aimed at younger gamers, but we’ve narrowed things down to a definitive top 10, which was no easy feat. You’ll find everything from party games, racers, platformers, open-world releases, and more. We’ve considered everything from the best Switch games for families to younger kids, so no one will be left out by any titles on the list.
More | Talk | Read It Later | Share

Stories Related to Sanofi Launches Hostile $18.5 Billion Bid For Genzyme

Comment On This Story

Welcome to Wopular

MoviesWithButter : Our Sister Site

More Business News